chr19-10350910-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003331.5(TYK2):​c.3488A>G​(p.Glu1163Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00388 in 1,614,180 control chromosomes in the GnomAD database, including 94 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E1163K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0032 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0039 ( 90 hom. )

Consequence

TYK2
NM_003331.5 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.65

Publications

22 publications found
Variant links:
Genes affected
TYK2 (HGNC:12440): (tyrosine kinase 2) This gene encodes a member of the tyrosine kinase and, more specifically, the Janus kinases (JAKs) protein families. This protein associates with the cytoplasmic domain of type I and type II cytokine receptors and promulgate cytokine signals by phosphorylating receptor subunits. It is also a component of both the type I and type III interferon signaling pathways. As such, it may play a role in anti-viral immunity. A mutation in this gene has been associated with Immunodeficiency 35. [provided by RefSeq, Sep 2020]
TYK2 Gene-Disease associations (from GenCC):
  • immunodeficiency 35
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003331.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0062526166).
BP6
Variant 19-10350910-T-C is Benign according to our data. Variant chr19-10350910-T-C is described in ClinVar as Benign. ClinVar VariationId is 468764.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00322 (491/152300) while in subpopulation SAS AF = 0.0294 (142/4824). AF 95% confidence interval is 0.0255. There are 4 homozygotes in GnomAd4. There are 265 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003331.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TYK2
NM_003331.5
MANE Select
c.3488A>Gp.Glu1163Gly
missense
Exon 25 of 25NP_003322.3
TYK2
NM_001385204.1
c.3698A>Gp.Glu1233Gly
missense
Exon 25 of 25NP_001372133.1
TYK2
NM_001385203.1
c.3569A>Gp.Glu1190Gly
missense
Exon 26 of 26NP_001372132.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TYK2
ENST00000525621.6
TSL:1 MANE Select
c.3488A>Gp.Glu1163Gly
missense
Exon 25 of 25ENSP00000431885.1P29597
TYK2
ENST00000524462.5
TSL:1
c.2933A>Gp.Glu978Gly
missense
Exon 21 of 21ENSP00000433203.1E9PM19
TYK2
ENST00000531836.7
TSL:4
c.3488A>Gp.Glu1163Gly
missense
Exon 25 of 25ENSP00000436175.2P29597

Frequencies

GnomAD3 genomes
AF:
0.00322
AC:
490
AN:
152182
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00360
Gnomad ASJ
AF:
0.00432
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0288
Gnomad FIN
AF:
0.00207
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.00319
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00596
AC:
1498
AN:
251488
AF XY:
0.00757
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.00121
Gnomad ASJ exome
AF:
0.00397
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00176
Gnomad NFE exome
AF:
0.00360
Gnomad OTH exome
AF:
0.00603
GnomAD4 exome
AF:
0.00395
AC:
5773
AN:
1461880
Hom.:
90
Cov.:
31
AF XY:
0.00490
AC XY:
3563
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.000358
AC:
12
AN:
33480
American (AMR)
AF:
0.00157
AC:
70
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00386
AC:
101
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0306
AC:
2640
AN:
86256
European-Finnish (FIN)
AF:
0.00185
AC:
99
AN:
53414
Middle Eastern (MID)
AF:
0.0248
AC:
143
AN:
5762
European-Non Finnish (NFE)
AF:
0.00215
AC:
2395
AN:
1112012
Other (OTH)
AF:
0.00517
AC:
312
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
410
821
1231
1642
2052
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00322
AC:
491
AN:
152300
Hom.:
4
Cov.:
32
AF XY:
0.00356
AC XY:
265
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.000505
AC:
21
AN:
41570
American (AMR)
AF:
0.00360
AC:
55
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00432
AC:
15
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.0294
AC:
142
AN:
4824
European-Finnish (FIN)
AF:
0.00207
AC:
22
AN:
10614
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.00319
AC:
217
AN:
68028
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
28
56
84
112
140
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00380
Hom.:
9
Bravo
AF:
0.00255
Asia WGS
AF:
0.00866
AC:
30
AN:
3478
EpiCase
AF:
0.00502
EpiControl
AF:
0.00462

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Immunodeficiency 35 (2)
-
-
2
not specified (2)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.36
T
Eigen
Benign
0.042
Eigen_PC
Benign
0.13
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.20
T
MetaRNN
Benign
0.0063
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.65
N
PhyloP100
1.6
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.22
Sift
Uncertain
0.020
D
Sift4G
Benign
0.21
T
Varity_R
0.28
gMVP
0.28
Mutation Taster
=66/34
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs55886939;
hg19: chr19-10461586;
COSMIC: COSV99314465;
COSMIC: COSV99314465;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.